Novo Nordis Adr (NVO) Shareholder Lazard Asset Management Has Decreased Holding by $1.65 Million; Davis-Rea LTD Holding In Brookfield Infrastructure Partners LP (BIP) Was Has Raised

January 14, 2018 - By Hazel Jackson

Lazard Asset Management Llc decreased its stake in Novo Nordis Adr (NVO) by 89.71% based on its latest 2017Q3 regulatory filing with the SEC. Lazard Asset Management Llc sold 35,073 shares as the company’s stock rose 15.20% with the market. The institutional investor held 4,025 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $193,000, down from 39,098 at the end of the previous reported quarter. Lazard Asset Management Llc who had been investing in Novo Nordis Adr for a number of months, seems to be less bullish one the $132.50B market cap company. The stock increased 0.15% or $0.08 during the last trading session, reaching $55.04. About 1.10M shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since January 14, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.

Davis-Rea Ltd increased its stake in Brookfield Infrastructure Partners Lp (BIP) by 3.9% based on its latest 2017Q3 regulatory filing with the SEC. Davis-Rea Ltd bought 7,185 shares as the company’s stock rose 9.21% with the market. The institutional investor held 191,365 shares of the marine transportation company at the end of 2017Q3, valued at $8.22 million, up from 184,180 at the end of the previous reported quarter. Davis-Rea Ltd who had been investing in Brookfield Infrastructure Partners Lp for a number of months, seems to be bullish on the $17.20B market cap company. The stock increased 1.06% or $0.46 during the last trading session, reaching $43.67. About 240,071 shares traded. Brookfield Infrastructure Partners L.P. (NYSE:BIP) has risen 38.95% since January 14, 2017 and is uptrending. It has outperformed by 22.25% the S&P500.




Among 9 analysts covering Brookfield Infrastructure Partners (NYSE:BIP), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Brookfield Infrastructure Partners had 33 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, September 26 by TD Securities. The stock of Brookfield Infrastructure Partners L.P. (NYSE:BIP) earned “Buy” rating by BMO Capital Markets on Wednesday, November 1. RBC Capital Markets maintained Brookfield Infrastructure Partners L.P. (NYSE:BIP) rating on Friday, July 14. RBC Capital Markets has “Buy” rating and $4400 target. As per Tuesday, August 18, the company rating was maintained by Scotia Capital. RBC Capital Markets maintained Brookfield Infrastructure Partners L.P. (NYSE:BIP) rating on Friday, September 8. RBC Capital Markets has “Buy” rating and $45.0 target. The rating was maintained by RBC Capital Markets on Friday, June 9 with “Buy”. The stock of Brookfield Infrastructure Partners L.P. (NYSE:BIP) earned “Outperform” rating by Raymond James on Monday, September 26. The company was upgraded on Friday, June 16 by Credit Suisse. Scotia Capital maintained Brookfield Infrastructure Partners L.P. (NYSE:BIP) on Thursday, August 6 with “Sector Perform” rating. The stock has “Outperform” rating by RBC Capital Markets on Thursday, February 4.

Analysts await Novo Nordisk A/S (NYSE:NVO) to report earnings on February, 1. They expect $0.56 EPS, up 12.00% or $0.06 from last year’s $0.5 per share. NVO’s profit will be $1.35B for 24.57 P/E if the $0.56 EPS becomes a reality. After $0.62 actual EPS reported by Novo Nordisk A/S for the previous quarter, Wall Street now forecasts -9.68% negative EPS growth.

Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 20 analyst reports since August 28, 2015 according to SRatingsIntel. The stock of Novo Nordisk A/S (NYSE:NVO) earned “Sell” rating by UBS on Monday, February 8. The rating was upgraded by JP Morgan on Friday, December 29 to “Neutral”. On Friday, December 1 the stock rating was upgraded by Morgan Stanley to “Overweight”. The stock of Novo Nordisk A/S (NYSE:NVO) earned “Buy” rating by Bank of America on Wednesday, December 6. The firm earned “Hold” rating on Friday, August 28 by Zacks. The rating was upgraded by HSBC on Wednesday, August 31 to “Hold”. As per Tuesday, December 6, the company rating was upgraded by UBS. The firm has “Underperform” rating given on Friday, October 28 by Bank of America. The rating was upgraded by BNP Paribas on Tuesday, September 13 to “Outperform”. The stock of Novo Nordisk A/S (NYSE:NVO) has “Neutral” rating given on Friday, September 23 by Piper Jaffray.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts